JPH0129764B2 - - Google Patents

Info

Publication number
JPH0129764B2
JPH0129764B2 JP55074701A JP7470180A JPH0129764B2 JP H0129764 B2 JPH0129764 B2 JP H0129764B2 JP 55074701 A JP55074701 A JP 55074701A JP 7470180 A JP7470180 A JP 7470180A JP H0129764 B2 JPH0129764 B2 JP H0129764B2
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP55074701A
Other versions
JPS56169622A (en
Inventor
Sumio Hatsuya
Morita Ryosei
Akira Wako
Original Assignee
Kissei Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kissei Pharmaceutical filed Critical Kissei Pharmaceutical
Priority to JP55074701A priority Critical patent/JPH0129764B2/ja
Publication of JPS56169622A publication Critical patent/JPS56169622A/en
Publication of JPH0129764B2 publication Critical patent/JPH0129764B2/ja
Application status is Expired legal-status Critical

Links

JP55074701A 1980-06-03 1980-06-03 Expired JPH0129764B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP55074701A JPH0129764B2 (en) 1980-06-03 1980-06-03

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP55074701A JPH0129764B2 (en) 1980-06-03 1980-06-03

Publications (2)

Publication Number Publication Date
JPS56169622A JPS56169622A (en) 1981-12-26
JPH0129764B2 true JPH0129764B2 (en) 1989-06-14

Family

ID=13554786

Family Applications (1)

Application Number Title Priority Date Filing Date
JP55074701A Expired JPH0129764B2 (en) 1980-06-03 1980-06-03

Country Status (1)

Country Link
JP (1) JPH0129764B2 (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2594693B1 (en) * 1986-02-24 1990-01-05 Farah Nabil New processes for preparing emulsions from dry solid oral forms has modified and delayed release of their active ingredients
FR2648708A2 (en) * 1986-02-24 1990-12-28 Farah Nabil Solid and semi-solid pharmaceutical preparations affording modified release of their active principles, using the "dry emulsions" process
US7101573B2 (en) * 2001-09-28 2006-09-05 Mcneil-Pcc, Inc. Simethicone solid oral dosage form
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
ITMI20021392A1 (en) * 2002-06-25 2003-12-29 Nicox Sa Pharmaceutical forms for oral administration of liquid drugs at room temperature with better bioavailability '
DE10336400A1 (en) 2003-08-06 2005-03-24 Grünenthal GmbH Abuse-proofed dosage form
US20070048228A1 (en) 2003-08-06 2007-03-01 Elisabeth Arkenau-Maric Abuse-proofed dosage form
DE102005005446A1 (en) 2005-02-04 2006-08-10 Grünenthal GmbH Unbreakable dosage forms with delayed release
JP5774853B2 (en) 2008-01-25 2015-09-09 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング pharmaceutical dosage form
MX2010012039A (en) 2008-05-09 2010-11-30 Gruenenthal Gmbh Process for the preparation of an intermediate powder formulation and a final solid dosage form under usage of a spray congealing step.
RU2547555C2 (en) 2009-07-22 2015-04-10 Грюненталь Гмбх Hot-melt extruded pharmaceutical dosage form
ES2718688T3 (en) 2009-07-22 2019-07-03 Gruenenthal Gmbh Tamper-resistant dosage form for oxidation-sensitive opioids
BR112013005194A2 (en) 2010-09-02 2016-05-03 Grünenthal GmbH tamper-resistant dosage form comprising inorganic salt
BR112013005234A2 (en) 2010-09-02 2016-05-03 Grünenthal GmbH Tamper resistant dosage form comprising an anionic polymer.
JP5901156B2 (en) * 2011-06-29 2016-04-06 地方独立行政法人東京都立産業技術研究センター Inorganic organic composite particles and method for producing the same
NO2736495T3 (en) 2011-07-29 2018-01-20
JP6117249B2 (en) 2012-02-28 2017-04-19 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング Tamper resistant dosage forms comprising a pharmacologically active compound and an anionic polymer
LT2838512T (en) 2012-04-18 2018-11-12 GrĆ¼nenthal GmbH Tamper resistant and dose-dumping resistant pharmaceutical dosage form
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
BR112015029616A2 (en) 2013-05-29 2017-07-25 Gruenenthal Gmbh tamper-resistant dosage form with bimodal release profile
EP3003279A1 (en) 2013-05-29 2016-04-13 Grünenthal GmbH Tamper-resistant dosage form containing one or more particles
CA2947786A1 (en) 2014-05-12 2015-11-19 Grunenthal Gmbh Tamper resistant immediate release capsule formulation comprising tapentadol
EA201692388A1 (en) 2014-05-26 2017-05-31 Грюненталь Гмбх Dosage form as particle multiple, protected against called dose reset by ethanol
JP2018517676A (en) 2015-04-24 2018-07-05 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング Anti-modification formulation with immediate release and resistance to solvent extraction

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4946585A (en) * 1972-09-11 1974-05-04

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4946585A (en) * 1972-09-11 1974-05-04

Also Published As

Publication number Publication date
JPS56169622A (en) 1981-12-26

Similar Documents

Publication Publication Date Title
DE3001874C2 (en)
DE3006460C2 (en)
DE3002410C2 (en)
DE3008332C2 (en)
DE3007743C2 (en)
DE3003869C2 (en)
CH655460B (en)
DE3000953C2 (en)
DE3006112C2 (en)
DE3001935C2 (en)
DE3002297C2 (en)
DE3001215C2 (en)
CH653577B (en)
CH655498B (en)
DE3007049C2 (en)
DE3001474C2 (en)
DE3004199C2 (en)
DE3004591C2 (en)
DE3006835C2 (en)
DE3007546C2 (en)
DE3001570C2 (en)
DE3002773C2 (en)
DE3006475C2 (en)
DE3006895C2 (en)
DE3003270C2 (en)